Baker Bros. Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Buy |
|
|||||
|
2025
Q1 | $11.7M | Sell |
|
|||||
|
2024
Q4 | $39M | Hold |
|
|||||
|
2024
Q3 | $39.1M | Hold |
|
|||||
|
2024
Q2 | $38.7M | Hold |
|
|||||
|
2024
Q1 | $42.8M | Hold |
|
|||||
|
2023
Q4 | $45.8M | Buy |
|
|||||
|
2023
Q3 | $25.7M | Hold |
|
|||||
|
2023
Q2 | $28.9M | Hold |
|
|||||
|
2023
Q1 | $26.9M | Hold |
|
|||||
|
2022
Q4 | $29.6M | Hold |
|
|||||
|
2022
Q3 | $27.1M | Hold |
|
|||||
|
2022
Q2 | $22.9M | Hold |
|
|||||
|
2022
Q1 | $23M | Hold |
|
|||||
|
2021
Q4 | $23.5M | Hold |
|
|||||
|
2021
Q3 | $11.5M | Hold |
|
|||||
|
2021
Q2 | $14M | Hold |
|
|||||
|
2021
Q1 | $13.5M | Buy |
|
|||||
|
2020
Q4 | $10.6M | Sell |
|
|||||
|
2020
Q3 | $8.42M | Sell |
|
|||||
|
2020
Q2 | $10M | Buy |
|